Home Purespring

Purespring

In operation
Series B
Developer of Kidney Disease Treatment Methods
Basic
Enterprise Profile

Basic Information

Purespring is leading a revolution in the treatment of kidney diseases. More than 8 million people in the UK and 840 million worldwide suffer from chronic kidney disease. Purespring aims to transform the current landscape by providing groundbreaking treatments for a range of kidney conditions. Making a real difference for patients suffering from these diseases and those supporting them is what drives us.
Purespring Therapeutics
London,England,United Kingdom
15~50 people
January 01, 2020
contact@purespringtx.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy
Technology
Gene Technology Cell Technology
Concept
Nephrology Department Rare Diseases Chronic Disease Therapeutic Products
Application Scenarios
Innovative Drugs Cell and Gene Therapy